P Düsing, A Zietzer, PR Goody, MR Hosen… - Journal of molecular …, 2021 - Springer
Cardiovascular disease (CVD) is a major cause of death in patients with chronic kidney disease (CKD). Both conditions are rising in incidence as well as prevalence, creating poor …
1–«МНОЦ МГУ им. МВ Ломоносова», 119192, Москва, Ломоносовский пр-кт, д. 27, корп. 10 2–ФГБОУ ВО «ПИМУ» МЗ РФ, 603950, Нижний Новгород, пл. Минина и Пожарского …
U Kumar, PS Garimella, N Wettersten - Cardiology clinics, 2019 - pmc.ncbi.nlm.nih.gov
The earliest mention of the term cardiorenal syndrome (CRS) came about from a 2004 National Heart, Lung, and Blood Institute Working Group conference evaluating the …
T Kadowaki, H Maegawa, H Watada… - Diabetes, Obesity …, 2022 - Wiley Online Library
Insights from epidemiological, clinical and basic research are illuminating the interplay between metabolic disorders, cardiovascular disease (CVD) and kidney dysfunction, termed …
Anaemia and iron deficiency (ID) are important co-morbidities in patients with chronic heart failure (HF) and both may lead to reduced exercise capacity. Methods We enrolled 331 out …
B Braam, JA Joles, AH Danishwar… - Nature Reviews …, 2014 - nature.com
Combined cardiac and renal dysfunction has gained considerable attention. Hypotheses about its pathogenesis have been formulated, albeit based on a relatively small body of …
Objectives: The study objective was to assess the association between angiotensin- converting enzyme inhibitor (ACEI)/angiotensin receptor blocker (ARB) use and mortality in …
Almost 200 years ago, the first evidence described by Robert Bright (1836) showed the strong interaction between the kidneys and heart and, since then, the scientific community …